|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net loss | |||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Interest earned on investments held in Trust Account | |||
| Depreciation and amortization | |||
| Non-cash interest expense | |||
| Share-based compensation expense | |||
| Provision for losses on receivables and inventory | |||
| Loss on impairment | |||
| Loss on extinguishment of debt | |||
| Change in fair value of warrant and derivative liabilities | |||
| Transaction cost allocable to warrants | |||
| Amortization of operating right-of-use assets | |||
| Other non-cash, net | |||
| Changes in operating assets and liabilities: | |||
| Accounts receivable, net | |||
| Contract assets | |||
| Inventory | |||
| Prepaid expenses and other current assets | |||
| Accounts payable and accrued expenses | |||
| Accounts payable | |||
| Contract liabilities | |||
| Reserve for anticipated losses on contracts | |||
| Accrued expenses and other current liabilities | |||
| Accrued interest | |||
| Other, net | |||
| Net cash used in operating activities | |||
| Cash flows from investing activities: | |||
| Investment of cash in Trust Account | |||
| Purchases of property, plant and equipment | |||
| Net cash used in investing activities | |||
| Cash flows from financing activities: | |||
| Proceeds from sale of Units, net of underwriting discounts paid | |||
| Proceeds from long-term debt | |||
| Proceeds from warrants and derivatives | |||
| Advances from related party | |||
| Repayment of promissory note-related party | |||
| Proceeds from Tailwind Two Merger and PIPE Investment | |||
| Proceeds from issuance of common stock | |||
| Committed Equity Facility | |||
| Total proceeds from issuance of common stock | |||
| Proceeds from Issuance of Common Stock under Committed Equity Facility | |||
| Repayment of long-term debt | |||
| Payment of issuance costs | |||
| Proceeds from exercise of stock options | |||
| Exercise of equity-classified warrants | |||
| Payment of withholding taxes on net share settlements | |||
| Net cash provided by financing activities | |||
| Effect of exchange rate fluctuations on cash and cash equivalents | |||
| Net (decrease) increase in cash and cash equivalents | |||
| Cash and cash equivalents at beginning of period | |||
| Cash and cash equivalents at end of period | |||
| Offering costs included in accrued offering costs | |||
| Offering costs paid through promissory note | |||
| Deferred underwriting fee payable | |||
| Non-cash investing and financing activities: | |||
| Interest paid, net of amounts capitalized | |||
| Interest capitalized to property, plant, and equipment not yet paid | |||
| Purchases of property, plant, and equipment not yet paid | |||
| Reclassification of property, plant, and equipment to inventory and prepaid expenses and other current assets | |||
| Depreciation and amortization capitalized to construction-in-process | |||
| Issuance costs not yet paid | |||
| Non-cash exchange and extinguishment of long-term debt | |||
| Issuance of common stock in exchange for non-controlling interest | |||
| Conversion of redeemable convertible preferred stock into common stock | |||
| Net settlement of liability-classified warrants into common stock | |||
| Net settlement of equity-classified warrants into common stock | |||
| Non-cash issuance of common stock in connection with PIPE Investment | |||
| Non-cash issuance of common stock in connection with financing transactions | |||
| Reclassification of liability-classified warrants and derivatives to equity-classified | |||
| Issuance of contingently issuable common stock |
Loading...